Two postdoctoral positions are available in the laboratory of Dr. Paul Burridge in the Department of Pharmacology and the Center for Pharmacogenomics at Northwestern University Feinberg School of Medicine, Chicago, IL.
Successful candidates will be involved in studies related to:
- Human iPSC-derived cardiomyocytes to model the pharmacogenomic basis of doxorubicin-, tyrosine kinase inhibitor-, and checkpoint inhibitor-induced cardiovascular toxicity including arrhythmia and atherosclerosis.
- Development of very large scale hiPSC cardiac differentiation.
- Development of bovine and porcine reprogramming, culture, and differentiation techniques for cultivated meat.
Qualifications: PhD or PharmD degree within the last two years and a strong record of peer-reviewed publications, including first author publications, is essential.
Desirable expertise includes: iPSC reprogramming (human, bovine, and porcine), iPSC culture, and differentiation methodologies (cardiac and skeletal muscle); bioreactors; hiPSC disease modeling; bioinformatics, genomics, GWAS; drug response assays; chemotherapy drug response/toxicity mechanisms.
Good verbal and written communication skills in English are essential. The successful candidate will join a dynamic research environment in the Department of Pharmacology, which offers both basic science and clinical translational opportunities to explore fundamental questions in pharmacogenomics.
Salary will be according to NIH (NRSA) Scale and commensurate with experience.
Please send a CV, a cover letter containing a brief description of research experience and interests, and a list of 2-3 references to: email@example.com
Northwestern University is an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. Women, racial and ethnic minorities, individuals with disabilities, and veterans are encouraged to apply. Hiring is contingent upon eligibility to work in the United States.